SEC Form 4 · accession 0001061983-18-000017
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Caryn Gordon McDowell
Officer — GC & Chief Compliance Officer
Period of report
Feb 27, 2018
Accepted (ET)
Mar 1, 2018 · 7:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2018 | A | 20,000 | $0.001 | A | 35,000 | D | |
| Common Stock | Feb 28, 2018 | F | 2,452 | $7.75 | D | 32,548 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F2 | $7.80 | Feb 27, 2018 | A | 15,226 | A | — | Feb 27, 2028 | Common Stock | 15,226 | 15,226 | D |
| Non-Qualified Stock Option (right to buy)F2 | $7.80 | Feb 27, 2018 | A | 14,774 | A | — | Feb 27, 2028 | Common Stock | 14,774 | 14,774 | D |
Explanation of responses
- F1The restricted stock units vest in three annual installments. Vested shares will be delivered to the reporting person as follows: 40% on 02/27/2019, 40% on 02/27/2020 and 20% on 03/01/2021.
- F2When the ISO and NQ dated 02/27/2018 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/27/2022.